← ANALYSTS · TIPRANKS
Debjit Chattopadhyay · Guggenheim
Hits
48%
238 of 493 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+17.0%
Over a year after the rating, TipRanks’ measure
Our companies rated now
21
Buy / hold / sell: 20 / 1 / 0
Upside of the analyst’s targets
+247.8%
Average over 20 current targets, to the last price
The market’s answer to the ratings
+3.7%
Day-0 move against SPY in the rating’s direction, average over 15 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Sep 23on TipRanks 06:15 | EDITIWMEditas Medicine · $375M | Upgrade | Buy | $5.00 | +112.8% | −7.2%next day +2.3% · 5 days −3.8% | ↗ |
| Sep 17on TipRanks Sep 18 07:10 | BMRNBioMarin Pharmaceutical · $10.8B | Reiterated | Buy | $86.00 | +57.3% | −0.6%next day −1.9% · 5 days −6.6% | ↗ |
| Sep 14on TipRanks Sep 15 07:35 | IONSIonis Pharmaceuticals · $7.0B | Reiterated | Buy | $89.00 → $80.00−10.1% | +86.3% | −4.7%next day −7.7% · 5 days −14.6% | ↗ |
| Sep 9on TipRanks Sep 10 07:10 | PHVSPharvaris · $2.1B | Reiterated | Buy | $40.00 → $44.00+10.0% | +58.6% | +0.2%next day 0.0% · 5 days +0.6% | ↗ |
| Aug 18on TipRanks Aug 19 05:36 | SCTXIWMScribe Therapeutics Inc. · $392M | Initiated | Buy | $50.00 | +149.0% | +28.6%next day +14.3% · 5 days +15.3% | ↗ |
| Aug 17on TipRanks 07:20 | SPRBIWMSpruce Biosciences · $119M | Reiterated | Buy | $123 → $104−15.4% | +162.3% | +1.0%next day +0.5% · 5 days +12.0% | ↗ |
| Aug 11on TipRanks Aug 12 07:10 | NGNEIWMNeurogene · $479M | Reiterated | Buy | $69.00 → $81.00+17.4% | +248.4% | −1.7%next day +3.0% · 5 days 0.0% | ↗ |
| Aug 3on TipRanks Aug 4 07:51 | RAREIWMUltragenyx Pharmaceutical · $1.5B | Reiterated | Buy | $43.00 → $35.00−18.6% | +140.7% | −1.0%next day +1.4% · 5 days +5.1% | ↗ |
| Jul 6on TipRanks 08:25 | EWTXIWMEdgewise Therapeutics · $4.1B | Reiterated | Buy | $41.00 → $51.00+24.4% | +37.1% | +0.5%next day +8.0% · 5 days +3.2% | ↗ |
| Jun 15on TipRanks 06:45 | RZLTIWMRezolute · $377M | Assigned | Buy | $6.00 → $11.00+83.3% | +207.3% | +6.5%next day +6.1% · 5 days +15.5% | ↗ |
| Jun 10on TipRanks 07:00 | BNTCIWMBenitec Biopharma · $289M | Downgrade | Hold | — | — | −2.3%next day +4.7% · 5 days +11.4% | ↗ |
| Jun 8on TipRanks Jul 1 20:45 | PEPGPepGen Inc. · $166M | Reiterated | Buy | $7.00 | +169.2% | −4.5%next day +2.5% · 5 days +11.2% | |
| Jun 5on TipRanks Jun 8 07:11 | TRDAIWMEntrada Therapeutics Inc · $177M | Reiterated | Buy | $20.00 → $17.00−15.0% | +289.0% | −6.4%next day −2.0% · 5 days +0.8% | ↗ |
| Jun 4on TipRanks 06:20 | IRDIWMOpus Genetics · $337M | Initiated | Buy | $16.00 | +316.7% | +10.1%next day −10.6% · 5 days −13.2% | ↗ |
| Jun 2on TipRanks 07:15 | VYGRIWMVoyager Therapeutics · $124M | Reiterated | Buy | $22.00 | +1,057.9% | −5.4%next day +1.0% · 5 days −1.5% | ↗ |
| May 28on TipRanks 11:06 | DTILIWMPrecision BioSciences · $170M | Reiterated | Buy | $19.00 | +229.3% | −9.4%next day +0.5% · 5 days −7.7% | ↗ |
| May 7on TipRanks May 8 07:30 | NAMSNewAmsterdam Pharma Company · $2.4B | Reiterated | Buy | $45.00 | +126.9% | +12.8%next day +10.3% · 5 days +3.6% | ↗ |
| May 4on TipRanks May 5 07:15 | KRYSIWMKrystal Biotech · $9.8B | Reiterated | Buy | $284 | −10.3% | +8.2%next day −1.6% · 5 days +6.1% | ↗ |
| Mar 20on TipRanks 06:35 | SLDBIWMSolid Biosciences · $615M | Initiated | Buy | $26.00 | +370.2% | +0.2%next day +0.5% · 5 days +3.4% | ↗ |
| Mar 4on TipRanks 07:25 | MAZEIWMMaze Therapeutics, Inc. · $1.5B | Assigned | Buy | $46.00 → $58.00+26.1% | +110.7% | +4.5%next day −2.0% · 5 days +9.8% | ↗ |
| Oct 15on TipRanks 06:35 | LXEOIWMLexeo Therapeutics, Inc. · $227M | Initiated | Buy | $30.00 | +1,036.4% | +3.4%next day 0.0% · 5 days +4.1% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗